Table 4.
Correlation between anthropometric and dietary variables with left ventricular ejection fraction variation at the completion of doxorubicin treatment and one-year follow-up
| Baseline variables | Δ LVEF | |
|---|---|---|
| Completion of DOX treatment – baseline | One-year follow-up – baseline | |
| Anthropometric measures | ||
| Body surface | –0.384 (p = 0.070) | –0.541 ( p = 0.011) |
| Body weight | –0.326 (p = 0.130) | –0.509 ( p = 0.018) |
| BMI | –0.212 (p = 0.331) | –0.475 ( p = 0.029) |
| Fat mass | –0.154 (p = 0.482) | –0.421 (p = 0.057) |
| Muscle mass | 0.316 (p = 0.142) | 0.467 ( p = 0.033) |
| Visceral fat | –0.151 (p = 0.491) | –0.502 ( p = 0.020) |
| Neck circumference | –0.138 (p = 0.530) | –0.579 ( p = 0.006) |
| Waist circumference | –0.201 (p = 0.358) | –0.423 (p = 0.056) |
| Dietary intake | ||
| Total calories | –0.324 (p = 0.132) | –0.039 (p = 0.868) |
| Carbohydrates | 0.137 (p = 0.532) | 0.400 (p = 0.072) |
| Proteins | –0.276 (p = 0.203) | –0.233 (p = 0.310) |
| Lipids | –0.021 (p = 0.925) | –0.336 (p = 0.137) |
| Cholesterol* | –0.144 (p = 0.513) | –0.201 (p = 0.382) |
| Saturated fat* | –0.292 (p = 0.176) | –0.028 (p = 0.904) |
| Sodium* | 0.084 (p = 0.702) | –0.149 (p = 0.519) |
LVEF, left ventricular ejection fraction; DOX, doxorubicin; BMI, body mass index; Pearson “r” correlation except for (*) where Spearman “r” correlation was used (p < 0.05)